Genetically engineered microalgae for enhanced bioactive compounds.

Microalgae are naturally rich in carbohydrates, lipids, proteins, pigments, minerals, and vitamins. These metabolites make them a renewable and sustainable source of bioactive compounds in nutraceuticals, food, feed for aquaculture, and biofuels. Genetic engineering of the existing strains remains crucial in utilising and upscaling microalgae-based biorefineries. CRISPR/Cas9, TALENs, ZFNs, and genetic transformation are the established tools utilised in microalgae genetic engineering. The common genetic transformation methods include electroporation, particle bombardment (biolistics), glass-bead agitation, and Agrobacterium-mediated transformation. Expression vectors and promoters are the prerequisites in genetic engineering. The present accessibility of genome sequences and omics datasets from a diverse array of microalgae species holds promise for catalyzing strategic progress in developing a superior microalgae strain suitable for numerous applications. This paper describes the genetic engineering to enhance microalgae biomass and metabolite production, particularly lipids. The advantages and precautions to fulfil the future application of genetically engineered microalgae are also reviewed and addressed.Article highlights: Strategic genetic engineering optimises microalgae strains for enhanced lipid synthesis and biomolecule production. CRISPR/Cas9 enables precise genome modifications in microalgae, enhancing their potential for various applications. Establishing regulatory frameworks for genetically modified (GM) microalgae is crucial for safe deployment. [ABSTRACT FROM AUTHOR]